Profile photo Renske ten Ham

Renske ten Ham

Assistant Professor

Strategic program(s):

Biography

Renske ten Ham is an assistant professor at the UMC Utrecht in the Netherlands and specializes in health economics & health technology assessment (HTA) of regenerative medicines, including gene and cell-based therapies. Trained as a pharmacist and with an MSc in HTA, she holds a PhD in Drug Innovation titled: “Development, market authorization and market access of gene- and cell-based therapies”.

 

Over the years Renske conducted research at the University of California, San Francisco (UCSF) and the Center of Health Economics at the University of York and collaborated with many more. She also spent time at the Dutch Medicines Evaluation Board (CBG-MEB) and Dutch National Health Care Institute (Zorginstituut Nederland). She is the recipient of the CHE Research Fellowship and an NWO VENI Laureate.

 

At the Julius Center Renske is lead of the Regenerative Medicines (RM) team within the Health Economic Evaluation-group. She strives to increase translation of RM and (academic) gene and cell-based therapies towards implementation in healthcare services. In doing so her research focusses on payment models, development cost, (early) economic evaluations and funding/business models. She aims to contribute to better understanding of the fit between innovative therapies and existing development frameworks. This is not only relevant for RM but also for future biomedical innovations.

Research groups

Health economic evaluation

Research aim

We aim to inform decision makers – developers, clinicians, patients and policy makers – to achieve affordable, accessible and high-quality healthcare.

Go to group

Recent publications

The ethics and economics of organoid commercialization Hanna de Groot, Manon van Daal, Regina W Hofland, Inez Bronsveld, Karin R Jongsma, Renske M T Ten Ham
BMC Medical Ethics, 2025, vol. 26
The ESOT–Lancet Commission on Transplantation: a new vision for global sustainability, innovation, and equity in organ transplantation Gabriel Oniscu, Elmi muller, Chloe Wilson, Richard Horton, Elias Mossialos, Vivekanand Jha, Alexander Loupy, Dominique E Martin, Beatriz Domínguez-Gil, Benita Padilla, Ifeoma Ulasi, Alex Ekwueme, Deepali Kumar, Maarten Naesens, RMT ten Ham, Peter P Reese, Dorry Segev, Ole F Norheim, John Rose, Daniel Gallego-Zurro, Santiago Torales, Milka Bengochea, Wenshi Jiang, Luciano Potena, Marta López-Fraga
The Lancet, 2025, vol. 406, p.313-315
What Does Pharmaceutical 3D Printing Cost? A Framework and Case Study with Hydrocortisone for Adrenal Insufficiency Sejad Ayyoubi, Liesbeth Ruijgrok, Hugo van der Kuy, Renske ten Ham, Frederick Thielen
PharmacoEconomics - open, 2025, vol. 9, p.207-215
Santander Statement , Beatriz Dominguez-Gil, RMT ten Ham
Transplantation, 2025, vol. 109, p.7-9
Shaping the potential of a Dutch ATMP network Joyce M. Hoek, Daniël O Warmerdam, Sophie E Berends, Benien E Vingerhoed-van Aken, Mariëtte H E Driessens, Babs O Fabriek, J. Francisco Hernandez, Pauline Meij, Connie C M van Oers, Pieter Stolk, RMT ten Ham, Lourens T Bloem
2024
A Systematic Review of Challenges and Opportunities in the Implementation of Managed Entry Agreements for Advanced Therapy Medicinal Products Andrea Greco, Geert W J Frederix, Lotty Hooft, Renske M T Ten Ham
Clinical Therapeutics, 2024, vol. 47, p.e16-e26

Fellowships & Awards

NWO VENI Laureate 2023/2024

  • The Veni is an annually awarded, personal scientific grant and part of the NWO Talent Program.
  • With this grant I will develop new methods using Bayesian statistics to reduce uncertainty in cost-effectiveness analyses to better inform reimbursement decisions using gene therapies for spinal muscular atrophy and hemophilia B as case studies.

CHE Research Fellowship Award 2023/2024

  • By Centre for Health Economics (CHE) of the University of York, UK
  • Research Fellowship to visit CHE in 2024 for three months to work on Innovative payment mechanisms for gene therapies: moving from theory to practice using the case of haemophillia.

Greiner Award 2020&2021

  • Award for the best thesis defended in 2020&2021
  • By Dutch Association of Gene & Cell Therapy (NVGCT)

Publication featured as Trends Editors Pick 2020

  • Journal: Trends in Pharmacological Sciences
  • Awarded publication: Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection.

Publication featured as  Editors Pick 2020

  • Journal: Value in Health
  • Awarded publication: A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature.

Best Scientific Poster 2019

  • Conference: TOPRA Conference 2019
  • Awarded poster: Challenges in Advanced Therapy Medicinal Product Development